Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

2.0K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.0K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

209
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
209
Pneumonia IV: Management01:28

Pneumonia IV: Management

324
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
324
Vaccinations01:51

Vaccinations

44.5K
Overview
44.5K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

236
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
236
Preventive Healthcare Services01:30

Preventive Healthcare Services

1.0K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Is Immediate Lymphatic Reconstruction Cost-Effective for Breast Cancer Lymphedema?

Plastic and reconstructive surgery·2026
Same author

Mechanical venous thrombectomy may provide a cost-effective treatment option for patients with iliofemoral deep vein thrombosis.

Journal of vascular surgery. Venous and lymphatic disorders·2026
Same author

Integrating primary care for depression management during transition in sickle cell disease: A pre-post feasibility study.

British journal of haematology·2026
Same author

Cost-Effectiveness of Adjunctive Middle Meningeal Artery Embolization for Chronic Subdural Hematoma: Secondary Analysis of EMBOLISE.

AJNR. American journal of neuroradiology·2026
Same author

Impact of Serotype Uncertainty on Adult Pneumococcal Vaccine Options: A Value of Information Analysis.

American journal of preventive medicine·2026
Same author

Protection of metabolic-hemodynamic coupling by nimodipine in an animal model of cerebral small vessel disease.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism·2026

Related Experiment Video

Updated: Jul 1, 2025

Experimental Human Pneumococcal Carriage
07:47

Experimental Human Pneumococcal Carriage

Published on: February 15, 2013

15.6K

Pneumococcal Vaccination Strategies in 50-Year-Olds to Decrease Racial Disparities: A US Societal Perspective

Shoroq M Altawalbeh1, Angela R Wateska2, Mary Patricia Nowalk3

  • 1Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Department of Clinical Pharmacy, Jordan University of Science and Technology Faculty of Pharmacy, Irbid, Jordan.

Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|March 10, 2024
PubMed
Summary
This summary is machine-generated.

Expanding pneumococcal vaccination (PCV20) to all 50-year-olds is cost-effective, especially for Black populations, to reduce racial disparities in pneumococcal disease. This strategy offers greater effectiveness and lower costs compared to current recommendations.

Keywords:
cost-effectivenessdisparitiespneumococcal diseasesocietal perspective

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.1K
A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

2.5K

Related Experiment Videos

Last Updated: Jul 1, 2025

Experimental Human Pneumococcal Carriage
07:47

Experimental Human Pneumococcal Carriage

Published on: February 15, 2013

15.6K
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.1K
A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

2.5K

Area of Science:

  • Public Health
  • Health Economics
  • Vaccinology

Background:

  • Racial disparities exist in pneumococcal disease burden.
  • Pneumococcal vaccination strategies aim to reduce disease incidence and severity.
  • Evaluating new vaccines like PCV20 is crucial for public health policy.

Purpose of the Study:

  • To assess the cost-effectiveness of expanding pneumococcal vaccination to all 50-year-olds.
  • To compare 20-valent pneumococcal conjugate vaccine (PCV20) and 15-valent conjugate vaccine/23-valent polysaccharide vaccine (PCV15/PPSV23) strategies.
  • To evaluate the impact on racial disparities from a societal perspective.

Main Methods:

  • A lifetime Markov model was utilized for cost-effectiveness analysis.
  • Compared PCV20 and PCV15/PPSV23 for 50- and 65-year-olds against current US recommendations and no vaccination.
  • Included US Black and non-Black cohorts, incorporating direct and indirect societal costs.

Main Results:

  • PCV20 for all at ages 50 and 65 was the most cost-effective strategy in Black cohorts.
  • In non-Black cohorts, PCV20 at 50 and 65 showed a favorable cost-effectiveness ratio ($62,083/QALY).
  • PCV15/PPSV23 strategies were consistently more costly and less effective than PCV20.

Conclusions:

  • PCV20 at ages 50 and 65 is a potentially economically viable strategy for the general US population.
  • This strategy is particularly beneficial for reducing pneumococcal disease burden and disparities in Black cohorts.
  • The findings support the expansion of PCV20 vaccination to younger age groups.